Just saw this on the website
Uropathogenic Escherichia Coli (UPEC): Pre Clinical work has begun at Monash University using a novel Hyper immune anti UPEC product produced by Immuron to treat one of the most common diseases, Urinary Tract Infections.
T2 diabetes - likely perfect target, page-28
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
-0.001(1.37%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.2¢ | 7.2¢ | $3.325K | 46.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 114000 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 217134 | 4 |
View Market Depth
| Last trade - 10.56am 12/11/2024 (20 minute delay) ? |
| IMC (ASX) Chart |